Carolina Journal by Video - CCII: Carolina Journal’s Donna King assesses Moore v. Harper redistricting case | Eastern NC Now

Donna King, Carolina Journal editor-in-chief, discusses the Moore v. Harper N.C. congressional redistricting case at the U.S. Supreme Court.

ENCNow
    Publisher's Note: This post appears here courtesy of the Carolina Journal. Presented in this Carolina Journal video broadcast is Donna King.

    The Carolina Journal makes a wide sweeping evaluation of the news that most effects us here in North Carolina, and is distilled, here on BCN, for your clear understanding by the electronic means of video broadcast.



    Donna King, Carolina Journal editor-in-chief, discusses the Moore v. Harper N.C. congressional redistricting case at the U.S. Supreme Court. King offered these comments during the Dec. 2, 2022, edition of PBS North Carolina’s “Front Row with Marc Rotterman.”

    Publisher's note: If you find these video vignettes informative, you can find all of the Carolina Journal TV videos here.
Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published )
Enter Your Comment ( text only please )




Brunson v. Alma S. Adams Carolina Journal, Editorials, Op-Ed & Politics Carolina Journal by Video - CCIII: Locke’s Mitch Kokai analyzes Moore v. Harper N.C. congressional redistricting case


HbAD0

Latest Op-Ed & Politics

this will help populist anti-immigration right in next year's presidential election
Unloaded on President Donald Trump in a series of profanity-laced private text messages

HbAD1

The tour bus will make 63 stops across 13 states across the country, and will end on Election Day in November.
the need for a pro-America curriculum in our schools

HbAD2

Organizations are quietly using foreign money to move the needle toward their preferred political outcomes.
illegal alien "asylum seeker" migrants are a crime wave on both sides of the Atlantic
Democrats are still calling Israel the biggest foreign lobby in America — and they’re using it to win the 2026 midterms.

HbAD3

 
 
Back to Top